Global Platinum based Cancer Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 95

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Platinum based Cancer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Platinum based Cancer Drug size is estimated to be XX million in 2021 from USD 1526.2 million in 2020, with a change of XX% between 2020 and 2021. The global Platinum based Cancer Drug market size is expected to grow at a CAGR of 2.6% for the next five years.

Market segmentation
Platinum based Cancer Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Cisplatin
    Oxaliplatin
    Carboplatin
    Others

Market segment by Application can be divided into
    Colorectal Cancer
    Ovarian Cancer
    Lung Cancer
    Others

The key market players for global Platinum based Cancer Drug market are listed below:
    Sanofi
    Hengrui Medicine
    ASK Pharma
    Yi Bai Pharmaceutical
    Qilu Pharmaceutical
    Teva
    Pfizer
    Dr Reddy's Laboratories
    Mylan
    Sun Pharma
    Novartis
    Debiopharm
    Accord Healthcare
    SK Chemicals

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Platinum based Cancer Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Platinum based Cancer Drug, with price, sales, revenue and global market share of Platinum based Cancer Drug from 2019 to 2021.
Chapter 3, the Platinum based Cancer Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum based Cancer Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Platinum based Cancer Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Platinum based Cancer Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Platinum based Cancer Drug Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Cisplatin
        1.2.3 Oxaliplatin
        1.2.4 Carboplatin
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Platinum based Cancer Drug Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Colorectal Cancer
        1.3.3 Ovarian Cancer
        1.3.4 Lung Cancer
        1.3.5 Others
    1.4 Global Platinum based Cancer Drug Market Size & Forecast
        1.4.1 Global Platinum based Cancer Drug Sales in Value (2016-2026))
        1.4.2 Global Platinum based Cancer Drug Sales in Volume (2016-2026)
        1.4.3 Global Platinum based Cancer Drug Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Platinum based Cancer Drug Production Capacity Analysis
        1.5.1 Global Platinum based Cancer Drug Total Production Capacity (2016-2026)
        1.5.2 Global Platinum based Cancer Drug Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Platinum based Cancer Drug Market Drivers
        1.6.2 Platinum based Cancer Drug Market Restraints
        1.6.3 Platinum based Cancer Drug Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Platinum based Cancer Drug Product and Services
        2.1.4 Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Hengrui Medicine
        2.2.1 Hengrui Medicine Details
        2.2.2 Hengrui Medicine Major Business
        2.2.3 Hengrui Medicine Platinum based Cancer Drug Product and Services
        2.2.4 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 ASK Pharma
        2.3.1 ASK Pharma Details
        2.3.2 ASK Pharma Major Business
        2.3.3 ASK Pharma Platinum based Cancer Drug Product and Services
        2.3.4 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Yi Bai Pharmaceutical
        2.4.1 Yi Bai Pharmaceutical Details
        2.4.2 Yi Bai Pharmaceutical Major Business
        2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Product and Services
        2.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Qilu Pharmaceutical
        2.5.1 Qilu Pharmaceutical Details
        2.5.2 Qilu Pharmaceutical Major Business
        2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Product and Services
        2.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Platinum based Cancer Drug Product and Services
        2.6.4 Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Platinum based Cancer Drug Product and Services
        2.7.4 Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Dr Reddy's Laboratories
        2.8.1 Dr Reddy's Laboratories Details
        2.8.2 Dr Reddy's Laboratories Major Business
        2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Product and Services
        2.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Mylan
        2.9.1 Mylan Details
        2.9.2 Mylan Major Business
        2.9.3 Mylan Platinum based Cancer Drug Product and Services
        2.9.4 Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Sun Pharma
        2.10.1 Sun Pharma Details
        2.10.2 Sun Pharma Major Business
        2.10.3 Sun Pharma Platinum based Cancer Drug Product and Services
        2.10.4 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Platinum based Cancer Drug Product and Services
        2.11.4 Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Debiopharm
        2.12.1 Debiopharm Details
        2.12.2 Debiopharm Major Business
        2.12.3 Debiopharm Platinum based Cancer Drug Product and Services
        2.12.4 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Accord Healthcare
        2.13.1 Accord Healthcare Details
        2.13.2 Accord Healthcare Major Business
        2.13.3 Accord Healthcare Platinum based Cancer Drug Product and Services
        2.13.4 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 SK Chemicals
        2.14.1 SK Chemicals Details
        2.14.2 SK Chemicals Major Business
        2.14.3 SK Chemicals Platinum based Cancer Drug Product and Services
        2.14.4 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Platinum based Cancer Drug Sales by Manufacturer
    3.1 Global Platinum based Cancer Drug Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Platinum based Cancer Drug Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Platinum based Cancer Drug
    3.4 Market Concentration Rate
        3.4.1 Top 3 Platinum based Cancer Drug Manufacturer Market Share
        3.4.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share
    3.5 Global Platinum based Cancer Drug Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Platinum based Cancer Drug Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Platinum based Cancer Drug Market Size by Region
        4.1.1 Global Platinum based Cancer Drug Sales in Volume by Region (2016-2026)
        4.1.2 Global Platinum based Cancer Drug Revenue by Region (2016-2026)
    4.2 North America Platinum based Cancer Drug Revenue (2016-2026)
    4.3 Europe Platinum based Cancer Drug Revenue (2016-2026)
    4.4 Asia-Pacific Platinum based Cancer Drug Revenue (2016-2026)
    4.5 South America Platinum based Cancer Drug Revenue (2016-2026)
    4.6 Middle East and Africa Platinum based Cancer Drug Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Platinum based Cancer Drug Sales in Volume by Type (2016-2026)
    5.2 Global Platinum based Cancer Drug Revenue by Type (2016-2026)
    5.3 Global Platinum based Cancer Drug Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Platinum based Cancer Drug Sales in Volume by Application (2016-2026)
    6.2 Global Platinum based Cancer Drug Revenue by Application (2016-2026)
    6.3 Global Platinum based Cancer Drug Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Platinum based Cancer Drug Sales by Type (2016-2026)
    7.2 North America Platinum based Cancer Drug Sales by Application (2016-2026)
    7.3 North America Platinum based Cancer Drug Market Size by Country
        7.3.1 North America Platinum based Cancer Drug Sales in Volume by Country (2016-2026)
        7.3.2 North America Platinum based Cancer Drug Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Platinum based Cancer Drug Sales by Type (2016-2026)
    8.2 Europe Platinum based Cancer Drug Sales by Application (2016-2026)
    8.3 Europe Platinum based Cancer Drug Market Size by Country
        8.3.1 Europe Platinum based Cancer Drug Sales in Volume by Country (2016-2026)
        8.3.2 Europe Platinum based Cancer Drug Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Platinum based Cancer Drug Sales by Type (2016-2026)
    9.2 Asia-Pacific Platinum based Cancer Drug Sales by Application (2016-2026)
    9.3 Asia-Pacific Platinum based Cancer Drug Market Size by Region
        9.3.1 Asia-Pacific Platinum based Cancer Drug Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Platinum based Cancer Drug Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Platinum based Cancer Drug Sales by Type (2016-2026)
    10.2 South America Platinum based Cancer Drug Sales by Application (2016-2026)
    10.3 South America Platinum based Cancer Drug Market Size by Country
        10.3.1 South America Platinum based Cancer Drug Sales in Volume by Country (2016-2026)
        10.3.2 South America Platinum based Cancer Drug Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Platinum based Cancer Drug Sales by Type (2016-2026)
    11.2 Middle East & Africa Platinum based Cancer Drug Sales by Application (2016-2026)
    11.3 Middle East & Africa Platinum based Cancer Drug Market Size by Country
        11.3.1 Middle East & Africa Platinum based Cancer Drug Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Platinum based Cancer Drug Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Platinum based Cancer Drug Typical Distributors
    12.3 Platinum based Cancer Drug Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Platinum based Cancer Drug Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Platinum based Cancer Drug Revenue by Application, (USD Million), 2021-2026
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Platinum based Cancer Drug Product and Services
    Table 6. Sanofi Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
    Table 8. Hengrui Medicine Major Business
    Table 9. Hengrui Medicine Platinum based Cancer Drug Product and Services
    Table 10. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. ASK Pharma Basic Information, Manufacturing Base and Competitors
    Table 12. ASK Pharma Major Business
    Table 13. ASK Pharma Platinum based Cancer Drug Product and Services
    Table 14. ASK Pharma Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Yi Bai Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 16. Yi Bai Pharmaceutical Major Business
    Table 17. Yi Bai Pharmaceutical Platinum based Cancer Drug Product and Services
    Table 18. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 20. Qilu Pharmaceutical Major Business
    Table 21. Qilu Pharmaceutical Platinum based Cancer Drug Product and Services
    Table 22. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Teva Basic Information, Manufacturing Base and Competitors
    Table 24. Teva Major Business
    Table 25. Teva Platinum based Cancer Drug Product and Services
    Table 26. Teva Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 28. Pfizer Major Business
    Table 29. Pfizer Platinum based Cancer Drug Product and Services
    Table 30. Pfizer Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
    Table 32. Dr Reddy's Laboratories Major Business
    Table 33. Dr Reddy's Laboratories Platinum based Cancer Drug Product and Services
    Table 34. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Mylan Basic Information, Manufacturing Base and Competitors
    Table 36. Mylan Major Business
    Table 37. Mylan Platinum based Cancer Drug Product and Services
    Table 38. Mylan Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Sun Pharma Basic Information, Manufacturing Base and Competitors
    Table 40. Sun Pharma Major Business
    Table 41. Sun Pharma Platinum based Cancer Drug Product and Services
    Table 42. Sun Pharma Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Novartis Basic Information, Manufacturing Base and Competitors
    Table 44. Novartis Major Business
    Table 45. Novartis Platinum based Cancer Drug Product and Services
    Table 46. Novartis Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Debiopharm Basic Information, Manufacturing Base and Competitors
    Table 48. Debiopharm Major Business
    Table 49. Debiopharm Platinum based Cancer Drug Product and Services
    Table 50. Debiopharm Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Accord Healthcare Basic Information, Manufacturing Base and Competitors
    Table 52. Accord Healthcare Major Business
    Table 53. Accord Healthcare Platinum based Cancer Drug Product and Services
    Table 54. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. SK Chemicals Basic Information, Manufacturing Base and Competitors
    Table 56. SK Chemicals Major Business
    Table 57. SK Chemicals Platinum based Cancer Drug Product and Services
    Table 58. SK Chemicals Platinum based Cancer Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 59. Global Platinum based Cancer Drug Sales by Manufacturer (2019-2021e) & (K Units)
    Table 60. Global Platinum based Cancer Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 61. Market Position of Manufacturers in Platinum based Cancer Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 62. Global Platinum based Cancer Drug Production Capacity by Company, (K Units): 2020 VS 2021
    Table 63. Head Office and Platinum based Cancer Drug Production Site of Key Manufacturer
    Table 64. Platinum based Cancer Drug New Entrant and Capacity Expansion Plans
    Table 65. Platinum based Cancer Drug Mergers & Acquisitions in the Past Five Years
    Table 66. Global Platinum based Cancer Drug Sales by Region (2016-2021e) & (K Units)
    Table 67. Global Platinum based Cancer Drug Sales by Region (2021-2026) & (K Units)
    Table 68. Global Platinum based Cancer Drug Revenue by Region (2016-2021e) & (USD Million)
    Table 69. Global Platinum based Cancer Drug Revenue by Region (2021-2026) & (USD Million)
    Table 70. Global Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 71. Global Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 72. Global Platinum based Cancer Drug Revenue by Type (2016-2021e) & (USD Million)
    Table 73. Global Platinum based Cancer Drug Revenue by Type (2021-2026) & (USD Million)
    Table 74. Global Platinum based Cancer Drug Price by Type (2016-2021e) & (USD/Unit)
    Table 75. Global Platinum based Cancer Drug Price by Type (2021-2026) & (USD/Unit)
    Table 76. Global Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 77. Global Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 78. Global Platinum based Cancer Drug Revenue by Application (2016-2021e) & (USD Million)
    Table 79. Global Platinum based Cancer Drug Revenue by Application (2021-2026) & (USD Million)
    Table 80. Global Platinum based Cancer Drug Price by Application (2016-2021e) & (USD/Unit)
    Table 81. Global Platinum based Cancer Drug Price by Application (2021-2026) & (USD/Unit)
    Table 82. North America Platinum based Cancer Drug Sales by Country (2016-2021e) & (K Units)
    Table 83. North America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units)
    Table 84. North America Platinum based Cancer Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 85. North America Platinum based Cancer Drug Revenue by Country (2021-2026) & (USD Million)
    Table 86. North America Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 87. North America Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 88. North America Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 89. North America Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 90. Europe Platinum based Cancer Drug Sales by Country (2016-2021e) & (K Units)
    Table 91. Europe Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units)
    Table 92. Europe Platinum based Cancer Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 93. Europe Platinum based Cancer Drug Revenue by Country (2021-2026) & (USD Million)
    Table 94. Europe Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 95. Europe Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 96. Europe Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 97. Europe Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 98. Asia-Pacific Platinum based Cancer Drug Sales by Region (2016-2021e) & (K Units)
    Table 99. Asia-Pacific Platinum based Cancer Drug Sales by Region (2021-2026) & (K Units)
    Table 100. Asia-Pacific Platinum based Cancer Drug Revenue by Region (2016-2021e) & (USD Million)
    Table 101. Asia-Pacific Platinum based Cancer Drug Revenue by Region (2021-2026) & (USD Million)
    Table 102. Asia-Pacific Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 103. Asia-Pacific Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 104. Asia-Pacific Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 105. Asia-Pacific Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 106. South America Platinum based Cancer Drug Sales by Country (2016-2021e) & (K Units)
    Table 107. South America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units)
    Table 108. South America Platinum based Cancer Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 109. South America Platinum based Cancer Drug Revenue by Country (2021-2026) & (USD Million)
    Table 110. South America Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 111. South America Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 112. South America Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 113. South America Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 114. Middle East & Africa Platinum based Cancer Drug Sales by Country (2016-2021e) & (K Units)
    Table 115. Middle East & Africa Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units)
    Table 116. Middle East & Africa Platinum based Cancer Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 117. Middle East & Africa Platinum based Cancer Drug Revenue by Country (2021-2026) & (USD Million)
    Table 118. Middle East & Africa Platinum based Cancer Drug Sales by Type (2016-2021e) & (K Units)
    Table 119. Middle East & Africa Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units)
    Table 120. Middle East & Africa Platinum based Cancer Drug Sales by Application (2016-2021e) & (K Units)
    Table 121. Middle East & Africa Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units)
    Table 122. Direct Channel Pros & Cons
    Table 123. Indirect Channel Pros & Cons
    Table 124. Platinum based Cancer Drug Typical Distributors
    Table 125. Platinum based Cancer Drug Typical Customers
List of Figures
    Figure 1. Platinum based Cancer Drug Picture
    Figure 2. Global Platinum based Cancer Drug Sales Market Share by Type in 2020
    Figure 3. Cisplatin
    Figure 4. Oxaliplatin
    Figure 5. Carboplatin
    Figure 6. Others
    Figure 7. Global Platinum based Cancer Drug Sales Market Share by Application in 2020
    Figure 8. Colorectal Cancer
    Figure 9. Ovarian Cancer
    Figure 10. Lung Cancer
    Figure 11. Others
    Figure 12. Global Platinum based Cancer Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 13. Global Platinum based Cancer Drug Market Size and Forecast (2016-2026) & (USD Million)
    Figure 14. Global Platinum based Cancer Drug Sales (2016-2026) & (K Units)
    Figure 15. Global Platinum based Cancer Drug Price by Type (2016-2026) & (USD/Unit)
    Figure 16. Global Platinum based Cancer Drug Production Capacity (2016-2026) & (K Units)
    Figure 17. Global Platinum based Cancer Drug Production Capacity by Geographic Region: 2020 VS 2021
    Figure 18. Platinum based Cancer Drug Market Drivers
    Figure 19. Platinum based Cancer Drug Market Restraints
    Figure 20. Platinum based Cancer Drug Market Trends
    Figure 21. Global Platinum based Cancer Drug Sales Market Share by Manufacturer in 2020
    Figure 22. Global Platinum based Cancer Drug Revenue Market Share by Manufacturer in 2020
    Figure 23. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 24. Top 3 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2020
    Figure 25. Top 6 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2020
    Figure 26. Global Platinum based Cancer Drug Sales Market Share by Region (2016-2026)
    Figure 27. Global Platinum based Cancer Drug Revenue Market Share by Region (2016-2026)
    Figure 28. North America Platinum based Cancer Drug Revenue (2016-2026) & (USD Million)
    Figure 29. Europe Platinum based Cancer Drug Revenue (2016-2026) & (USD Million)
    Figure 30. Asia-Pacific Platinum based Cancer Drug Revenue (2016-2026) & (USD Million)
    Figure 31. South America Platinum based Cancer Drug Revenue (2016-2026) & (USD Million)
    Figure 32. Middle East & Africa Platinum based Cancer Drug Revenue (2016-2026) & (USD Million)
    Figure 33. Global Platinum based Cancer Drug Sales Market Share by Type (2016-2026)
    Figure 34. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2026)
    Figure 35. Global Platinum based Cancer Drug Price by Type (2016-2026) & (USD/Unit)
    Figure 36. Global Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 37. Global Platinum based Cancer Drug Revenue Market Share by Application (2016-2026)
    Figure 38. Global Platinum based Cancer Drug Price by Application (2016-2026) & (USD/Unit)
    Figure 39. North America Platinum based Cancer Drug Sales Market Share by Type (2016-2026)
    Figure 40. North America Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 41. North America Platinum based Cancer Drug Sales Market Share by Country (2016-2026)
    Figure 42. North America Platinum based Cancer Drug Revenue Market Share by Country (2016-2026)
    Figure 43. United States Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Platinum based Cancer Drug Sales Market Share by Type (2016-2026)
    Figure 47. Europe Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 48. Europe Platinum based Cancer Drug Sales Market Share by Country (2016-2026)
    Figure 49. Europe Platinum based Cancer Drug Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Region (2016-2026)
    Figure 58. Asia-Pacific Platinum based Cancer Drug Revenue Market Share by Region (2016-2026)
    Figure 59. China Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Japan Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Korea Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. India Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Southeast Asia Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Australia Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South America Platinum based Cancer Drug Sales Market Share by Type (2016-2026)
    Figure 66. South America Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 67. South America Platinum based Cancer Drug Sales Market Share by Country (2016-2026)
    Figure 68. South America Platinum based Cancer Drug Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Type (2016-2026)
    Figure 72. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Application (2016-2026)
    Figure 73. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Country (2016-2026)
    Figure 74. Middle East & Africa Platinum based Cancer Drug Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Egypt Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. South Africa Platinum based Cancer Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Related Reports

Global Platinum based Cancer Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Platinum based Cancer Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Pharma & Healthcare

The Platinum based Cancer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Platinum based Cancer Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Platinum based Cancer Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Global Platinum based Cancer Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Platinum based Cancer Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Global Platinum based Cancer Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Platinum based Cancer Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Platinum based Cancer Drug market size was valued at USD 1586.5 million in 2023 and is forecast to a readjusted size of USD 1896.7 million by 2030 with a CAGR of 2.6% during review period.

Global Platinum based Cancer Drug Supply, Demand and Key Producers, 2024-2030

Global Platinum based Cancer Drug Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Pharma & Healthcare

The global Platinum based Cancer Drug market size is expected to reach $ 1896.7 million by 2030, rising at a market growth of 2.6% CAGR during the forecast period (2024-2030).

Product Tags

platinum based cancer drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>